Carson K.P. Wong

Mr. Wong’s recent representative experience, includes advising:

Capital Markets

• The underwriters on the initial public offering of AIM Vaccine on the Main Board of The Stock Exchange of Hong Kong
• Tianqi Lithium on its initial public offering on the Main Board of The Stock Exchange of Hong Kong
• The underwriters on the initial public offering of Transcenta on the Main Board of The Stock Exchange of Hong Kong
• The underwriters on the initial public offering of Suzhou Basecare on the Main Board of The Stock Exchange of Hong Kong
• The underwriters on the initial public offering of Guizhou Bank on the Main Board of The Stock Exchange of Hong Kong
• The underwriters on the initial public offering of Alphamab Oncology on the Main Board of The Stock Exchange of Hong Kong
• SGX Catalist-listed LHN Limited on its dual primary listing on the Main Board of The Stock Exchange of Hong Kong*
• Minsheng Education Group on its initial public offering on the Main Board of The Stock Exchange of Hong Kong*
• China New Higher Education Group on its initial public offering on the Main Board of The Stock Exchange of Hong Kong*
• The underwriters on the initial public offering of AL Group on The Stock Exchange of Hong Kong *

Private Equity/M&A

• The purchaser on acquisition of a PRC estate development SPV in connection with the settlement of a shareholders’ dispute
• Hendale Capital on its investment in NinePoint Medical, a US-based medical device company*
• A vendor on a sale of PRC tourism business*
• The founder of a Hong Kong-based technology company on a shareholder dispute following private equity investments in form of convertible bonds*
• A well-known YouTuber on the formation of a joint venture with a global entertainment company*

*Matter handled prior to joining Latham